Atlas Trials

A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

Clinical trial NCT01596088 · COMPLETED

Trial details

NCT number
NCT01596088
Sponsor
Kissei Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Extravasations of Anthracycline Anti-cancer Agents
Primary completion
2014-01-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.